GB201412821D0 - Polymeric proteins and uses thereof - Google Patents

Polymeric proteins and uses thereof

Info

Publication number
GB201412821D0
GB201412821D0 GBGB1412821.9A GB201412821A GB201412821D0 GB 201412821 D0 GB201412821 D0 GB 201412821D0 GB 201412821 A GB201412821 A GB 201412821A GB 201412821 D0 GB201412821 D0 GB 201412821D0
Authority
GB
United Kingdom
Prior art keywords
polymeric proteins
proteins
polymeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1412821.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liverpool School of Tropical Medicine
Original Assignee
Liverpool School of Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liverpool School of Tropical Medicine filed Critical Liverpool School of Tropical Medicine
Priority to GBGB1412821.9A priority Critical patent/GB201412821D0/en
Publication of GB201412821D0 publication Critical patent/GB201412821D0/en
Priority to GB1702637.8A priority patent/GB2543713B/en
Priority to PCT/GB2015/052098 priority patent/WO2016009232A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/35—Valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/524—CH2 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/53—Hinge
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
GBGB1412821.9A 2014-07-18 2014-07-18 Polymeric proteins and uses thereof Ceased GB201412821D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1412821.9A GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof
GB1702637.8A GB2543713B (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof
PCT/GB2015/052098 WO2016009232A1 (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1412821.9A GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof

Publications (1)

Publication Number Publication Date
GB201412821D0 true GB201412821D0 (en) 2014-09-03

Family

ID=51494824

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1412821.9A Ceased GB201412821D0 (en) 2014-07-18 2014-07-18 Polymeric proteins and uses thereof
GB1702637.8A Active GB2543713B (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1702637.8A Active GB2543713B (en) 2014-07-18 2015-07-20 Polymeric proteins and uses thereof

Country Status (2)

Country Link
GB (2) GB201412821D0 (en)
WO (1) WO2016009232A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214321A1 (en) 2016-06-07 2017-12-14 Gliknik Inc. Cysteine-optimized stradomers
KR20190032392A (en) 2016-07-22 2019-03-27 글리크닉 인코포레이티드 Fusion proteins of human protein fragments to produce regularly < RTI ID = 0.0 > mass < / RTI > immunoglobulin FC compositions with improved FC receptor binding
JP2020500856A (en) 2016-12-09 2020-01-16 グリックニック インコーポレイテッド Method for treating inflammatory disease using polyvalent FC compound
EP3765492A1 (en) * 2018-03-16 2021-01-20 Liverpool School of Tropical Medicine Chimeric fc receptor binding proteins and uses thereof
EP4342908A1 (en) * 2021-06-17 2024-03-27 Fapon Biotech Inc. Chimeric immunoglobulin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0922209D0 (en) * 2009-12-18 2010-02-03 Univ Nottingham Proteins, nucleic acid molecules and compositions

Also Published As

Publication number Publication date
WO2016009232A1 (en) 2016-01-21
GB201702637D0 (en) 2017-04-05
GB2543713A (en) 2017-04-26
GB2543713B (en) 2019-03-27

Similar Documents

Publication Publication Date Title
IL275307B (en) Syntac polypeptides and uses thereof
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL247407A0 (en) Anti-egfrviii antibodies and uses thereof
HK1231471A1 (en) 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof 6-- 6--2-
PL3152226T3 (en) Modified cyclopentapeptides and uses thereof
IL251001B (en) Anti-il-25 antibodies and uses thereof
GB2543713B (en) Polymeric proteins and uses thereof
GB201410031D0 (en) Polypeptides and uses thereof
SG11201610918RA (en) Peptides and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)